[ad_1]
The second substance, a protein called alpha-synuclein, is badociated with both Parkinson's disease and dementia.
Tests on rodents presenting a risk of "genetic" showed that the caffeine mixture with an EHT compound prevented the accumulation of alpha-synuclein after only 6 months.
The researchers conducted tests to evaluate learning abilities and memory in mice, reflecting activity in different parts of the brain, where they found marked improvement.
The researchers now hope to combine caffeine and HEH into one drug to help treat Parkinson's disease in humans.
Other studies are needed to determine the correct proportions of caffeine and ETH, to protect people from these two deadly diseases.
Source:
Russia today
Source link